Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowBone Marrow CellsLeukemiaTransplantation, AutologousTransplantation ConditioningWhole-Body IrradiationHematopoietic Stem Cell TransplantationTransplantation ChimeraAnemia, AplasticTissue DonorsGraft SurvivalBusulfanLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteLiver TransplantationHistocompatibility TestingRecurrenceHistocompatibilityGraft vs Tumor EffectTransplantation, IsogeneicHematologic NeoplasmsBone and BonesPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionCyclophosphamideLeukocyte TransfusionLymphocyte DepletionHematopoietic Stem CellsImmunosuppressive AgentsGraft vs Leukemia EffectRadiation ChimeraAcute DiseaseTreatment OutcomeBone Marrow PurgingKidney TransplantationGraft vs Host ReactionGraft RejectionCombined Modality TherapyTransplantation ImmunologyHepatic Veno-Occlusive DiseaseMice, Inbred C57BLLeukemia, MyeloidImmunosuppressionLymphocyte TransfusionTime FactorsStem Cell TransplantationT-LymphocytesMyelodysplastic SyndromesHematopoiesisSurvival AnalysisCyclosporineNuclear FamilyChimeraRetrospective StudiesHLA AntigensLymphoma, Non-HodgkinHeart TransplantationBone Marrow DiseasesSurvival RateActuarial AnalysisCytomegalovirus InfectionsGranulocyte Colony-Stimulating FactorHematologic DiseasesMice, Inbred BALB CAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalLung TransplantationSevere Combined ImmunodeficiencyMultiple MyelomaFollow-Up StudiesCytarabineBone Marrow ExaminationFatal OutcomePeripheral Blood Stem Cell TransplantationLymphomaSpleenNeoplasm, ResidualOrgan TransplantationBone RemodelingAntigens, CD34Leukocyte CountPancytopeniaBone Marrow NeoplasmsPrognosisColony-Forming Units AssaySalvage TherapyLeukemia, LymphoidFlow CytometryMethotrexateImmunophenotypingLife TablesEtoposideSkin TransplantationInfectionMelphalanHematopoietic Stem Cell MobilizationCord Blood Stem Cell Transplantation